Astrazeneca (AZN) Total Liabilities (2009 - 2026)

Astrazeneca's Total Liabilities history runs 18 years deep, the most recent figure standing at -$66.6 billion for Q1 2026.

• In Q1 2026, Total Liabilities fell 2.32% year-over-year to -$66.6 billion; the TTM figure through Mar 2026 stood at -$66.6 billion (down 2.32% YoY), while the FY2025 annual figure was -$65.4 billion, down 203.47% from the prior year.
• Total Liabilities was -$66.6 billion for Q1 2026 at Astrazeneca, down from -$65.4 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $63.2 billion in Q4 2024 to a low of -$68.5 billion in Q3 2025.
• Historically, Total Liabilities has averaged -$41.5 billion across 5 years, with a median of -$63.9 billion in 2022.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities grew 12.3% in 2022, then plunged 203.47% in 2025.
• A 5-year view of Total Liabilities shows it stood at $59.4 billion in 2022, then grew by 4.25% to $62.0 billion in 2023, then climbed by 1.95% to $63.2 billion in 2024, then slumped by 203.47% to -$65.4 billion in 2025, then retreated by 1.95% to -$66.6 billion in 2026.
• The last three Total Liabilities figures came in at -$66.6 billion (Q1 2026), -$65.4 billion (Q4 2025), and -$68.5 billion (Q3 2025), per Business Quant data.